SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-114263
Filing Date
2022-04-22
Accepted
2022-04-22 08:23:54
Documents
12
Period of Report
2022-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K d356716d8k.htm   iXBRL 8-K 28830
  Complete submission text file 0001193125-22-114263.txt   155815

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20220421.xsd EX-101.SCH 2872
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20220421_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20220421_pre.xml EX-101.PRE 11721
6 EXTRACTED XBRL INSTANCE DOCUMENT d356716d8k_htm.xml XML 3512
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 22843501
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences